Around 50 New Minish Provider Applications

Provided by Minish Technology

Provided by Minish Technology

View original image

Minish Technology announced on the 9th that it successfully concluded the "2nd Tokyo Minish Clinical Case Seminar and Corporate Presentation" held on the 8th at the Funai Soken head office lecture hall in Tokyo Midtown, Japan.


This event drew strong interest, with 170 participants, a 70% increase compared to the first event held in February last year. In addition, the collaborative framework between the two companies was strengthened, as Funai Soken, a major consulting firm in Japan, supported the provision of the venue and local marketing through a partnership.


The most notable change was in the composition of the speakers. At last year's seminar, which was at an early stage of Minish adoption, Korean medical staff led most of the lectures, whereas this year Japanese local dentists took the podium themselves.


This was made possible because, over the past year, the number of Minish provider dental clinics in Japan has rapidly increased to 25, creating a foundation for sharing locally accumulated clinical data and operational know-how.


The profile of attendees also changed. Unlike last year, when private practitioners were at the center, this year many officials from medical corporations operating multiple dental clinics and dentists from key areas of Tokyo attended in large numbers.


The seminar proceeded in the following order: ▲ History and future direction of Minish (CEO Kang Jungho) ▲ Minish process in Japan (Director Ahn Gilwoo of Anbi Dental Clinic in Shinjuku) ▲ Japanese dental market and the role of Minish (Takaaki Sato of Funai Soken) ▲ Presentation of local adoption cases (Director Taito Shimazaki).



A Minish Technology representative stated, "After this seminar, about 50 Japanese dentists expressed their intention to apply to become Minish providers," adding, "This means that Minish is being recognized in Japan not as a supplement to existing treatments, but as an independent treatment category."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing